Alyssa Morimoto

2.6k total citations
29 papers, 1.3k citations indexed

About

Alyssa Morimoto is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alyssa Morimoto has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alyssa Morimoto's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Retinal Diseases and Treatments (5 papers). Alyssa Morimoto is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Retinal Diseases and Treatments (5 papers). Alyssa Morimoto collaborates with scholars based in United States, United Kingdom and Argentina. Alyssa Morimoto's co-authors include Joseph B. Bolen, Michael J. Townsend, Alexander R. Abbas, Jacqueline McBride, William P. Kennedy, Romeo Maciuca, Hannele Ruohola‐Baker, Amy E. Berson, Robert Bookstein and Kristen Wolslegel and has published in prestigious journals such as Nature Genetics, Development and Oncogene.

In The Last Decade

Alyssa Morimoto

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alyssa Morimoto United States	18	631	454	318	234	199	29	1.3k
Toru Fukazawa Japan	19	710 1.1×	895 2.0×	250 0.8×	343 1.5×	393 2.0×	39	1.7k
Paul Chuchana France	21	763 1.2×	364 0.8×	231 0.7×	195 0.8×	217 1.1×	47	1.4k
Kathy Strauch United States	9	336 0.5×	919 2.0×	188 0.6×	173 0.7×	227 1.1×	10	1.3k
Gina M. Doody United Kingdom	26	956 1.5×	1.6k 3.5×	187 0.6×	328 1.4×	239 1.2×	56	2.4k
Barbara J. Schiemann United States	15	685 1.1×	807 1.8×	200 0.6×	484 2.1×	134 0.7×	17	1.8k
Hiroyuki Sugahara Japan	16	681 1.1×	974 2.1×	235 0.7×	237 1.0×	118 0.6×	36	1.9k
Yacine Laâbi France	16	600 1.0×	516 1.1×	77 0.2×	221 0.9×	120 0.6×	19	1.2k
Kevin T. Merrell United States	14	588 0.9×	761 1.7×	72 0.2×	170 0.7×	147 0.7×	17	1.4k
A W Harris Australia	9	500 0.8×	697 1.5×	104 0.3×	265 1.1×	174 0.9×	9	1.1k
Juan Saus Spain	22	754 1.2×	205 0.5×	122 0.4×	213 0.9×	198 1.0×	40	1.9k

Countries citing papers authored by Alyssa Morimoto

Since Specialization

Citations

This map shows the geographic impact of Alyssa Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyssa Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyssa Morimoto more than expected).

Fields of papers citing papers by Alyssa Morimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyssa Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyssa Morimoto. The network helps show where Alyssa Morimoto may publish in the future.

Co-authorship network of co-authors of Alyssa Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Alyssa Morimoto. A scholar is included among the top collaborators of Alyssa Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyssa Morimoto. Alyssa Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Looney, Cary M., Jay Garg, Thomas H. Schindler, et al.. (2023). Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients. Transplantation Direct. 9(2). e1436–e1436. 8 indexed citations

Cohen, Stanley, Katie Tuckwell, Tamiko R. Katsumoto, et al.. (2020). Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial. Arthritis & Rheumatology. 72(9). 1435–1446. 85 indexed citations

Isenberg, David, Richard Furie, Nicholas S. Jones, et al.. (2020). OP0233 EFFICACY, SAFETY, AND PHARMACODYNAMIC EFFECTS OF THE BRUTON'S TYROSINE KINASE INHIBITOR, FENEBRUTINIB (GDC-0853), IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS IN A PHASE 2 CONTROLLED STUDY. Annals of the Rheumatic Diseases. 79. 148–148. 13 indexed citations

Loyet, Kelly M., Philip E. Hass, Wendy Sandoval, et al.. (2018). In Vivo Stability Profiles of Anti-factor D Molecules Support Long-Acting Delivery Approaches. Molecular Pharmaceutics. 16(1). 86–95. 6 indexed citations

Cai, Fang, et al.. (2016). Bioanalytical Challenges and Improved Detection of Circulating Levels of Il-13. Bioanalysis. 8(4). 323–332. 15 indexed citations

Cowan, Kyra J., Xiaoying Gao, Lawren C. Wu, et al.. (2016). Fit-For-Purpose Biomarker Immunoassay Qualification and Validation: Three Case Studies. Bioanalysis. 8(22). 2329–2340. 6 indexed citations

Le, Kha, Leonid Gibiansky, Menno van Lookeren Campagne, et al.. (2015). A Mechanistic Pharmacokinetic/Pharmacodynamic Model of Factor D Inhibition in Cynomolgus Monkeys by Lampalizumab for the Treatment of Geographic Atrophy. Journal of Pharmacology and Experimental Therapeutics. 355(2). 288–296. 24 indexed citations

Bowsher, Ronald R., Mark J. Cameron, Viswanath Devanarayan, et al.. (2015). Recommendations for Adaptation and Validation of Commercial Kits for Biomarker Quantification in Drug Development. Bioanalysis. 7(2). 229–242. 19 indexed citations

Kennedy, William P., Romeo Maciuca, Kristen Wolslegel, et al.. (2015). Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE. Lupus Science & Medicine. 2(1). e000080–e000080. 104 indexed citations

10.

Loyet, Kelly M., Xiangdan Wang, Jihong Yang, et al.. (2014). Complement Inhibition in Cynomolgus Monkeys by Anti–Factor D Antigen-Binding Fragment for the Treatment of an Advanced Form of Dry Age-Related Macular Degeneration. Journal of Pharmacology and Experimental Therapeutics. 351(3). 527–537. 40 indexed citations

11.

Sepah, Yasir J., Mohamed Ibrahim, Alyssa Morimoto, et al.. (2013). To determine changes in levels of cytokines in the anterior chamber (AC) fluid of eyes in patients with diabetic macular edema (DME)whom have been treated with repeated injections of ranibizumab (RBZ). Investigative Ophthalmology & Visual Science. 54(15). 1149–1149. 1 indexed citations

12.

Li, Xue, Michele Fiscella, Manoj Rajadhyaksha, et al.. (2013). Pre-Existing Biotherapeutic-Reactive Antibodies: Survey Results Within the American Association of Pharmaceutical Scientists. The AAPS Journal. 15(3). 852–855. 34 indexed citations

13.

McBride, Jacqueline, Jenny Jiang, Alexander R. Abbas, et al.. (2012). Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo‐controlled, double‐blind, dose‐escalation study. Arthritis & Rheumatism. 64(11). 3666–3676. 146 indexed citations

14.

Morimoto, Alyssa, Jihong Yang, Kristen Wolslegel, et al.. (2011). Association of endogenous anti–interferon‐α autoantibodies with decreased interferon‐pathway and disease activity in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 63(8). 2407–2415. 92 indexed citations

15.

Loyet, Kelly M., Manda Wong, Alyssa Morimoto, et al.. (2010). Anti-Factor D Fab Specifically Inhibits the Alternative Complement Pathway: In vitro Characterization and in vivo Effects Following Administration to Cynomolgus Monkeys. Investigative Ophthalmology & Visual Science. 51(13). 2980–2980. 1 indexed citations

16.

Morimoto, Alyssa, Nguyêñ Duy Tân, Kristina West, et al.. (2004). Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor. Oncogene. 23(8). 1618–1626. 37 indexed citations

17.

Morimoto, Alyssa, Michael G. Tomlinson, Kaname Nakatani, et al.. (2000). The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity. Oncogene. 19(2). 200–209. 41 indexed citations

18.

Clegg, Nigel, Alyssa Morimoto, Jonaki Sen, et al.. (2000). The homeobox gene mirror links EGF signalling to embryonic dorso-ventral axis formation through Notch activation. Nature Genetics. 24(4). 429–433. 74 indexed citations

19.

Morimoto, Alyssa, Amy E. Berson, David H.‐F. Teng, et al.. (1999). Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase. Oncogene. 18(6). 1261–1266. 29 indexed citations

20.

Morimoto, Alyssa, et al.. (1999). Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN. Oncogene. 18(9). 1765–1769. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact